Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of ATG-F induction regimen using a single dose of
ATG-F compared with a five-day dose regimen of ATG-F in anew kidney transplant recipients.